BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23792450)

  • 1. Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA.
    Novitskaya V; Romanska H; Kordek R; Potemski P; Kusińska R; Parsons M; Odintsova E; Berditchevski F
    Oncogene; 2014 May; 33(21):2779-89. PubMed ID: 23792450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511.
    Yamada M; Sumida Y; Fujibayashi A; Fukaguchi K; Sanzen N; Nishiuchi R; Sekiguchi K
    FEBS J; 2008 Jul; 275(13):3335-51. PubMed ID: 18492066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151.
    Nishiuchi R; Sanzen N; Nada S; Sumida Y; Wada Y; Okada M; Takagi J; Hasegawa H; Sekiguchi K
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1939-44. PubMed ID: 15677332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.
    Yang XH; Flores LM; Li Q; Zhou P; Xu F; Krop IE; Hemler ME
    Cancer Res; 2010 Mar; 70(6):2256-63. PubMed ID: 20197472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms.
    Gustafson-Wagner E; Stipp CS
    PLoS One; 2013; 8(4):e61834. PubMed ID: 23613949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD151/Tspan24 and integrin alpha 3 complex in aid of prognostication of HER2-negative high-grade ductal carcinoma in situ.
    Romanska HM; Potemski P; Kusinska R; Kopczynski J; Sadej R; Kordek R
    Int J Clin Exp Pathol; 2015; 8(8):9471-8. PubMed ID: 26464707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.
    Baldwin G; Novitskaya V; Sadej R; Pochec E; Litynska A; Hartmann C; Williams J; Ashman L; Eble JA; Berditchevski F
    J Biol Chem; 2008 Dec; 283(51):35445-54. PubMed ID: 18852263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α3β1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments.
    Scales TM; Jayo A; Obara B; Holt MR; Hotchin NA; Berditchevski F; Parsons M
    Oncogene; 2013 Aug; 32(34):3965-79. PubMed ID: 22986527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells.
    Mieszkowska M; Piasecka D; Potemski P; Debska-Szmich S; Rychlowski M; Kordek R; Sadej R; Romanska HM
    Transl Res; 2019 May; 207():44-55. PubMed ID: 30639369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts.
    Johnson JL; Winterwood N; DeMali KA; Stipp CS
    J Cell Sci; 2009 Jul; 122(Pt 13):2263-73. PubMed ID: 19509057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
    Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
    Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion.
    Zevian SC; Johnson JL; Winterwood NE; Walters KS; Herndon ME; Henry MD; Stipp CS
    Cancer Biol Ther; 2015; 16(11):1626-40. PubMed ID: 26418968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells.
    Ranjan A; Bane SM; Kalraiya RD
    Exp Cell Res; 2014 Apr; 322(2):249-64. PubMed ID: 24530578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5.
    Winterwood NE; Varzavand A; Meland MN; Ashman LK; Stipp CS
    Mol Biol Cell; 2006 Jun; 17(6):2707-21. PubMed ID: 16571677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.
    Nagy P; Friedländer E; Tanner M; Kapanen AI; Carraway KL; Isola J; Jovin TM
    Cancer Res; 2005 Jan; 65(2):473-82. PubMed ID: 15695389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.
    Zevian S; Winterwood NE; Stipp CS
    J Biol Chem; 2011 Mar; 286(9):7496-506. PubMed ID: 21193415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
    Yoon SO; Shin S; Lipscomb EA
    Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
    Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
    Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.